Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-27 4:03 pm Purchase | 2020-11-17 | 13G | PINE IS ACQUISITION CORP UNIT PIPPU | CITADEL ADVISORS LLC | 1,500,000 6.900% | 1,500,000 (New Position) | Filing History |
| 2020-11-16 4:02 pm Purchase | 2020-11-05 | 13G | Teligent, Inc. TLGT | CITADEL ADVISORS LLC | 203,021 1.400% | 203,021 (New Position) | Filing History |
| 2020-11-02 4:03 pm Purchase | 2020-10-22 | 13G | Helix Acquisition Corp. HLXA | CITADEL ADVISORS LLC | 687,919 5.800% | 687,919 (New Position) | Filing History |
| 2020-10-26 4:01 pm Purchase | 2020-10-14 | 13G | Spruce Biosciences, Inc. SPRB | CITADEL ADVISORS LLC | 1,701,787 7.300% | 1,701,787 (New Position) | Filing History |
| 2020-10-13 4:08 pm Purchase | 2020-10-02 | 13G | Oncorus, Inc. ONCR | CITADEL ADVISORS LLC | 1,852,649 8.500% | 1,852,649 (New Position) | Filing History |
| 2020-10-08 4:02 pm Purchase | 2020-09-28 | 13G | PREVAIL THERAPEUTICS INC PRVL | CITADEL ADVISORS LLC | 2,413,881 7.100% | 2,413,881 (New Position) | Filing History |
| 2020-09-28 4:03 pm Purchase | 2020-09-17 | 13G | Dyne Therapeutics, Inc. DYN | CITADEL ADVISORS LLC | 2,945,951 6.500% | 2,945,951 (New Position) | Filing History |
| 2020-08-07 8:09 pm Purchase | 2020-07-28 | 13G | Annexon, Inc. ANNX | CITADEL ADVISORS LLC | 2,120,333 5.500% | 2,120,333 (New Position) | Filing History |
| 2020-07-31 4:31 pm Purchase | 2020-07-22 | 13G | Genocea Biosciences, Inc. GNCA | CITADEL ADVISORS LLC | 3,432,386 6.500% | 3,432,386 (New Position) | Filing History |
| 2020-07-10 4:02 pm Purchase | 2020-07-01 | 13G | Mereo BioPharma Group plc MREO | CITADEL ADVISORS LLC | 31,132,991 8.900% | 31,132,991 (New Position) | Filing History |
| 2020-06-10 5:07 pm Purchase | 2020-06-01 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | CITADEL ADVISORS LLC | 8,895,435 5.000% | 8,895,435 (New Position) | Filing History |